Ultrasound AI Market - Global Forecast To 2030
商品番号 : SMB-88169
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年8月 |
| ページ数 | 278 |
| 図表数 | 283 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
超音波AI市場 – 製品（AI対応システム（POCUS、ハンドヘルド、カート）、ソリューション（画像評価、放射線科））、ブランド（Echopac、Aplio、Acuson、Butterfly）、用途（産婦人科、心臓、整形外科）、エンドユーザー（病院、クリニック、ACC） – 2030年までの世界予測
世界の超音波AI市場は、2025年の23億5,000万米ドルから2030年には68億8,000万米ドルに達すると予測されており、予測期間中は年平均成長率（CAGR）24.0%で成長します。市場の成長は、正確かつ早期の疾患診断に対する需要の高まり、画像解析のための機械学習アルゴリズムの進歩、そしてワークフローの効率化と人的ミスの削減を目的としたAIの統合によって牽引されています。ポータブル型およびポイントオブケア型超音波装置の普及に加え、心臓病学、産婦人科学、腫瘍学、救急医療における用途の増加が、市場拡大をさらに促進すると予想されます。
超音波AI市場は、製品タイプ、ブランド、アプリケーション、エンドユーザー、地域別にセグメント化されています。市場の成長に影響を与える主な要因には、推進力、制約、機会、そしてステークホルダーにとっての課題が含まれます。本レポートでは、超音波AI市場で競合する主要企業についても分析しています。ミクロレベルの分析を行うことで、トレンド、成長機会、そして市場への貢献を分析できます。さらに、5つの主要地域における様々な市場セグメントにおける潜在的な収益成長機会についても明らかにしています。
本レポートは、市場に関する包括的な情報を提供するため、超音波AI市場への新規参入企業にとって貴重な情報となります。この情報は、様々な投資機会を理解する上で不可欠です。本レポートは、市場における主要企業と小規模企業の両方に関する洞察を提供し、投資判断を行う際のリスク分析の確固たる基盤の構築に役立ちます。エンドユーザーと地域別に市場を正確にセグメント化し、特定の市場セグメントに的を絞った洞察を提供しています。さらに、主要なトレンド、課題、成長ドライバー、そして機会を網羅し、徹底的な分析を通じて戦略的意思決定を支援します。
超音波AI市場の成長を促進する主な要因（慢性疾患の罹患率の上昇、ポータブル機器およびポイントオブケア機器との統合、AIアルゴリズムの進歩、医療費の増加と政府の支援政策、医療技術企業とAIスタートアップ企業のコラボレーションの増加）、制約（メンテナンスとアップグレードの高額な費用、規制上のハードルと承認の遅延）、機会（ポータブル超音波の拡張、電子健康記録との統合）、および課題（臨床医による導入への抵抗、データプライバシーとセキュリティの懸念）があります。
The global Ultrasound AI market is projected to reach USD 6.88 billion by 2030 from USD 2.35 billion in 2025, growing at a CAGR of 24.0% during the forecast period. The growth of the market is driven by the increasing demand for accurate and early disease diagnosis, advancements in machine learning algorithms for image analysis, and the integration of AI to enhance workflow efficiency and reduce human error. The rising adoption of portable and point-of-care ultrasound devices, coupled with growing applications in cardiology, obstetrics/gynecology, oncology, and emergency care, is further expected to fuel market expansion.
By product type, the AI-enabled solutions/software segment is expected to register the highest CAGR during the forecast period.
By product type, the AI-enabled solutions/software segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to the cost-efficiency and flexible provision to enhance diagnostic accuracy and workflow efficiency without the requirement of primary hardware upgrades. AI software benefits from scalability and continuous innovation. Unlike hardware, which requires significant investment cycles, software can be easily updated with new algorithms, clinical applications, and regulatory-compliant features. The growing adoption of cloud-based platforms, telemedicine, and remote diagnostics also expands the role of AI software in healthcare ecosystems, fueling market growth.
By brand, the EchoPAC segment accounted for the largest share of the market in 2024.
By brand, the EchoPAC segment accounts for the highest market share in the ultrasound AI market by brand because it is GE Healthcare’s widely adopted advanced analysis software, specifically designed for cardiovascular ultrasound. It offers robust AI-driven tools for strain imaging, 3D/4D quantification, and automated measurements, which significantly improve diagnostic accuracy and workflow efficiency. Its seamless integration with GE’s large installed base of ultrasound systems, strong clinical validation, and broad use across leading hospitals and cardiology centers worldwide give EchoPAC a competitive edge, enabling it to dominate market share in the AI-enabled ultrasound segment.
By end user, the hospitals & surgical centers segment accounted for the largest share of the market in 2024.
In 20254, the hospitals & surgical centers segment accounted for the largest share of the market due to its high patient inflow, broad range of diagnostic and interventional procedures, and extensive adoption of advanced imaging technologies. These facilities leverage AI-enabled ultrasound systems for accurate, efficient, and real-time imaging across various specialties, including cardiology, obstetrics/gynecology, oncology, and emergency care. The strong financial capacity, skilled workforce, and integration of AI tools into routine workflows further enhance operational efficiency and patient outcomes, solidifying their dominant position over other end-user segments such as research institutes or smaller clinics.
By region, the Asia Pacific is expected to register the highest growth rate in the market during the forecast period.
The Asia Pacific region is expected to witness the highest growth rate in the Ultrasound AI market due to rapid advancements in healthcare infrastructure, increasing adoption of advanced imaging technologies, and rising investments in AI-driven medical solutions. Factors such as a large and aging population, growing prevalence of chronic and lifestyle-related diseases, and expanding access to healthcare services in countries like China, India, and Japan are driving demand. Additionally, government initiatives promoting digital health, increasing awareness of early disease detection, and the entry of global and local Ultrasound AI manufacturers are further accelerating market expansion in the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (55%), Directors (27%), and Others (18%)
By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), and the Middle East & Africa (2%)
The prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), Hologic Inc. (US), Samsung Electronics Co., Ltd (South Korea), Butterfly Network (US), Chison Medical Technologies Co., Ltd (China), and Clarius (Canada), among others.
Research Coverage
The ultrasound AI market is segmented by product type, brand, application, end user, and region. Key factors influencing market growth include driving forces, restraints, opportunities, and challenges for stakeholders. The report also reviews the leading companies competing in the Ultrasound AI market. A micro-level analysis can be conducted to examine trends, growth opportunities, and contributions to the market. Additionally, it highlights potential revenue growth opportunities across various market segments in five major regions.
Key Benefits of Buying the Report
The report is valuable for new entrants in the Ultrasound AI market as it provides comprehensive information about the market. This information is essential for understanding various investment opportunities. The report offers insights into both key and smaller players in the market, which can help in creating a solid basis for risk analysis when making investment decisions. It accurately segments the market by end users and regions, providing focused insights into specific market segments. Additionally, the report highlights key trends, challenges, growth drivers, and opportunities to support strategic decision-making through a thorough analysis.
The report provides insights into the following points:
- Key drivers (rising prevalence of chronic diseases, integration with portable and point-of-care devices, advancements in AI algorithms, rising healthcare expenditure and supportive government policies, rising collaborations between med-tech companies and ai startups), restraints (high maintenance and upgrade costs, regulatory hurdles and approval delays), opportunities (expansion of portable ultrasound, integration with electronic health records), and challenges (resistance to adoption among clinicians, data privacy and security concerns) fueling the market growth of ultrasound ai market.
- Product Development/Innovation: Emerging technologies in space, R&D, recent product & service launches in the Ultrasound AI market.
- Market Growth: In-depth insights into remunerative markets report analyze the Ultrasound AI market across varied geographies.
- Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the Ultrasound AI market
- Competitive Assessment: Detailed assessment of market share, service offerings, leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), and FUJIFILM Corporation (Japan), among others.
Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 MARKET SCOPE 25
1.3.1 ULTRASOUND AI MARKET SEGMENTATION 25
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 27
1.5 MARKET STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY RESEARCH 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY RESEARCH 31
2.1.2.1 Key industry insights 32
2.2 MARKET SIZE ESTIMATION APPROACH 33
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 35
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 36
2.3 MARKET FORECASTING APPROACH 38
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 39
2.5 MARKET SHARE ASSESSMENT 40
2.6 RESEARCH ASSUMPTIONS 40
2.7 RESEARCH LIMITATIONS 40
2.8 RISK ASSESSMENT 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 ULTRASOUND AI MARKET OVERVIEW 45
4.2 NORTH AMERICA: ULTRASOUND AI MARKET, BY COUNTRY AND END USER, 2025 46
4.3 GEOGRAPHIC SNAPSHOT OF ULTRASOUND AI MARKET 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
5.2.1 DRIVERS 49
5.2.1.1 Integration with portable and point-of-care devices 49
5.2.1.2 Advancements in AI algorithms 50
5.2.1.3 Rising healthcare expenditure and supportive government policies 50
5.2.1.4 Rising collaboration between MedTech companies and AI startups 51
5.2.2 RESTRAINTS 52
5.2.2.1 High maintenance and upgrade costs 52
5.2.2.2 Regulatory hurdles and approval delays 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Expansion of portable ultrasound with AI integration 53
5.2.3.2 AI-driven fetal health monitoring 53
5.2.4 CHALLENGES 54
5.2.4.1 Resistance to adoption among clinicians 54
5.2.4.2 Data privacy and security concerns 54
5.3 VALUE CHAIN ANALYSIS 55
5.4 SUPPLY CHAIN ANALYSIS 56
5.4.1 PROMINENT COMPANIES 56
5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES 56
5.4.3 END USERS 56
5.5 PORTER’S FIVE FORCES ANALYSIS 57
5.5.1 THREAT OF NEW ENTRANTS 58
5.5.2 BARGAINING POWER OF SUPPLIERS 58
5.5.3 BARGAINING POWER OF BUYERS 58
5.5.4 THREAT OF SUBSTITUTES 59
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.6 KEY STAKEHOLDERS & BUYING CRITERIA 59
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 59
5.6.2 BUYING CRITERIA 60
5.7 PATENT ANALYSIS 62
5.8 TRADE DATA ANALYSIS 64
5.8.1 IMPORT DATA 64
5.8.2 EXPORT DATA 65
5.9 KEY CONFERENCES & EVENTS, 2025–2026 66
5.10 UNMET NEEDS AND KEY PAIN POINTS 67
5.11 ECOSYSTEM ANALYSIS 67
5.12 IMPACT OF 2025 US TARIFF―ULTRASOUND AI MARKET 68
5.12.1 INTRODUCTION 68
5.12.2 KEY TARIFF RATES 69
5.12.3 PRICE IMPACT ANALYSIS 69
5.12.4 IMPACT ON COUNTRY/REGION 70
5.12.4.1 US 70
5.12.4.2 Europe 70
5.12.4.3 Asia Pacific 70
5.12.5 IMPACT ON END USERS 71
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 72
5.14 TECHNOLOGY ANALYSIS 72
5.14.1 KEY TECHNOLOGIES 73
5.14.1.1 3D/4D imaging with AI enhancement 73
5.14.1.2 Cloud computing & data analytics 73
5.14.2 COMPLEMENTARY TECHNOLOGIES 73
5.14.2.1 Wearable devices & IoMT 73
5.14.3 ADJACENT TECHNOLOGIES 73
5.14.3.1 Positron emission tomography (PET) and molecular imaging 73
5.15 CASE STUDY ANALYSIS 74
5.15.1 IMV OFFERS EFFICIENT POWER FOR HANDHELD ULTRASOUND UNITS 74
5.15.2 ADVANCEMENTS IN USE OF ULTRASOUND AI PRE-HOSPITAL EMERGENCIES AND DISASTER RESPONSE SETTINGS 74
5.15.3 USE OF HANDHELD ULTRASOUND AI IN RURAL HOSPITAL IN GUATEMALA 75
5.16 REGULATORY ANALYSIS 75
5.16.1 NORTH AMERICA 75
5.16.1.1 US 75
5.16.1.2 Canada 76
5.16.2 EUROPE 77
5.16.3 ASIA PACIFIC 77
5.16.3.1 Japan 77
5.16.3.2 China 78
5.16.3.3 India 79
5.16.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.17 INVESTMENT & FUNDING SCENARIO 82
5.18 PRICING ANALYSIS 84
5.18.1 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022–2024 (USD) 85
5.18.2 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, 2024 (USD) 86
5.19 REIMBURSEMENT SCENARIO 87
6 ULTRASOUND AI MARKET, BY PRODUCT TYPE 88
6.1 INTRODUCTION 89
6.2 AI-ENABLED ULTRASOUND SYSTEMS 89
6.2.1 HANDHELD ULTRASOUND 90
6.2.1.1 Rapid diagnostic capabilities to drive market 90
6.2.2 CART-BASED ULTRASOUND 91
6.2.2.1 Enhanced clinical imaging to fuel growth 91
6.2.3 POINT OF CARE ULTRASOUND 93
6.2.3.1 Support for diverse clinical applications to lead market growth 93
6.3 AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE 94
6.3.1 IMAGE EVALUATION SOFTWARE 95
6.3.1.1 Enhanced clinical precision with ultrasound AI image analysis 95
6.3.2 RADIOLOGY SOFTWARE 96
6.3.2.1 Smart ultrasound diagnostics to boost growth 96
6.3.3 WORKFLOW PLANNING & SUPPORT SOFTWARE 97
6.3.3.1 Optimization of ultrasound workflow for better patient outcomes –
key driver 97
6.3.4 OTHER AI SOLUTIONS 98
7 ULTRASOUND AI MARKET, BY BRAND 100
7.1 INTRODUCTION 101
7.2 ECHOPAC 101
7.2.1 IMPROVED PATIENT EXPERIENCE WITH ECHOPAC SOFTWARE IN HOSPITALS AND SURGICAL CENTERS 101
7.3 APLIO 102
7.3.1 IMAGE OPTIMIZATION AND REAL-TIME DECISION SUPPORT TO FUEL MARKET GROWTH 102
7.4 ACUSON 103
7.4.1 ADVANCED DIAGNOSTICS WITH AI-BASED ACUSON SYSTEM 103
7.5 BUTTERFLY 104
7.5.1 INTEGRATION OF AI IN SMARTPHONES & TABLETS TO DRIVE MARKET GROWTH 104
7.6 OTHER BRANDS 105
8 ULTRASOUND AI MARKET, BY APPLICATION 107
8.1 INTRODUCTION 108
8.2 OBSTETRICS/GYNECOLOGY 108
8.2.1 HIGH LEVEL OF INNOVATION TO DRIVE MARKET 108
8.3 RADIOLOGY/GENERAL IMAGING 110
8.3.1 TRANSFORMING DIAGNOSTIC WORKFLOWS WITH INTEGRATED AI MODEL 110
8.4 ORTHOPEDIC & MUSCULOSKELETAL 112
8.4.1 RISING PREVALENCE OF OSTEOARTHRITIS TO LEAD MARKET GROWTH 112
8.5 CARDIOLOGY 113
8.5.1 ACCELERATED CARDIAC ASSESSMENTS WITH AI BORDER MAPPING TO DRIVE SEGMENT 113
8.6 UROLOGICAL 115
8.6.1 WIDE USE IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO BOOST MARKET 115
8.7 OTHER APPLICATIONS 116
9 ULTRASOUND AI MARKET, BY END USER 117
9.1 INTRODUCTION 118
9.2 HOSPITALS & SURGICAL CENTERS 118
9.2.1 HIGH ADOPTION OF AI-INTEGRATED ULTRASOUND TO BOOST MARKET 118
9.3 IMAGING & SPECIALTY CLINICS 119
9.3.1 EARLY DISEASE DETECTION AND PERSONALIZED TREATMENT LEAD TO MARKET GROWTH 119
9.4 AMBULATORY CARE CENTERS 120
9.4.1 SUPPORTIVE EARLY DETECTION & PREVENTIVE CARE TO PROPEL MARKET GROWTH 120
9.5 MATERNITY & FERTILITY CLINICS 121
9.5.1 AI INTEGRATION SYSTEMS LEAD TO PRECISE AND EFFICIENT TREATMENT 121
9.6 OTHER END USERS 122
10 ULTRASOUND AI MARKET, BY REGION 124
10.1 INTRODUCTION 125
10.2 NORTH AMERICA 126
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 126
10.2.2 US 131
10.2.2.1 Presence of advanced healthcare infrastructure to drive market 131
10.2.3 CANADA 133
10.2.3.1 Investments in healthcare AI to drive market 133
10.3 EUROPE 135
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 135
10.3.2 GERMANY 139
10.3.2.1 Favorable healthcare policies and regulatory landscape to drive market 139
10.3.3 UK 141
10.3.3.1 Funding by government bodies to drive market 141
10.3.4 FRANCE 142
10.3.4.1 Increasing demand for routine health check-ups, prenatal care,
and diagnostic procedures to drive market 142
10.3.5 ITALY 144
10.3.5.1 Increased availability of reimbursement coverage to drive market 144
10.3.6 SPAIN 146
10.3.6.1 Growing adoption of point-of-care ultrasound AI to drive market 146
10.3.7 REST OF EUROPE 148
10.4 ASIA PACIFIC 150
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 151
10.4.2 CHINA 155
10.4.2.1 Emphasis on modernization and expansion of healthcare infrastructure to drive market 155
10.4.3 JAPAN 158
10.4.3.1 Rise in breast cancer diagnosis using ultrasound AI to boost market 158
10.4.4 INDIA 160
10.4.4.1 Investments and funding activities to drive market 160
10.4.5 AUSTRALIA 162
10.4.5.1 Increasing investments in healthcare infrastructure to drive market 162
10.4.6 SOUTH KOREA 164
10.4.6.1 Rising investments in AI & conference events to drive market 164
10.4.7 REST OF ASIA PACIFIC 166
10.5 LATIN AMERICA 168
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 169
10.5.2 BRAZIL 173
10.5.2.1 Growing adoption of healthcare insurance to drive market 173
10.5.3 MEXICO 175
10.5.3.1 Investment in ultrasound AI devices to drive market 175
10.5.4 REST OF LATIN AMERICA 177
10.6 MIDDLE EAST & AFRICA 178
10.6.1 MACROECONOMIC OUTLOOK 179
10.6.2 GCC COUNTRIES 183
10.6.2.1 Government initiatives aimed at digital health and telemedicine to drive market 183
10.6.3 REST OF MIDDLE EAST & AFRICA 184
11 COMPETITIVE LANDSCAPE 187
11.1 INTRODUCTION 187
11.2 KEY PLAYER STRATEGIES 187
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND
AI MARKET 188
11.3 REVENUE ANALYSIS, 2021–2024 189
11.4 MARKET SHARE ANALYSIS, 2024 190
11.4.1 RANKING OF KEY MARKET PLAYERS 191
11.5 COMPANY EVALUATION MATRIX: ULTRASOUND AI MARKET, 2024 192
11.5.1 STARS 192
11.5.2 EMERGING LEADERS 192
11.5.3 PERVASIVE PLAYERS 192
11.5.4 PARTICIPANTS 192
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 194
11.5.5.1 Company footprint 194
11.5.5.2 Region footprint 195
11.5.5.3 Product footprint 196
11.5.5.4 Application footprint 197
11.5.5.5 End user footprint 198
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024) 199
11.6.1 PROGRESSIVE COMPANIES 199
11.6.2 RESPONSIVE COMPANIES 199
11.6.3 DYNAMIC COMPANIES 199
11.6.4 STARTING BLOCKS 199
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 201
11.6.5.1 Detailed list of key startups/SMEs 201
11.6.5.2 Competitive benchmarking of key startups/SMEs 202
11.7 COMPANY VALUATION & FINANCIAL METRICS 204
11.7.1 FINANCIAL METRICS 204
11.7.2 COMPANY VALUATION 204
11.8 BRAND/PRODUCT COMPARISON 205
11.9 COMPETITIVE SCENARIO 206
11.9.1 PRODUCT LAUNCHES 206
11.9.2 DEALS 207
12 COMPANY PROFILES 208
12.1 KEY PLAYERS 208
12.1.1 GE HEALTHCARE 208
12.1.1.1 Business overview 208
12.1.1.2 Products offered 209
12.1.1.3 Recent developments 210
12.1.1.3.1 Product launches & approvals 210
12.1.1.3.2 Deals 212
12.1.1.3.3 Other developments 212
12.1.1.4 MnM view 213
12.1.1.4.1 Right to win 213
12.1.1.4.2 Strategic choices 213
12.1.1.4.3 Weaknesses & competitive threats 213
12.1.2 PHILIPS HEALTHCARE 214
12.1.2.1 Business overview 214
12.1.2.2 Products offered 215
12.1.2.3 Recent developments 217
12.1.2.3.1 Product launches & approvals 217
12.1.2.3.2 Deals 218
12.1.2.4 MnM view 218
12.1.2.4.1 Right to win 218
12.1.2.4.2 Strategic choices 218
12.1.2.4.3 Weaknesses & competitive threats 218
12.1.3 CANON MEDICAL SYSTEMS CORPORATION 219
12.1.3.1 Business overview 219
12.1.3.2 Products offered 220
12.1.3.3 Recent developments 221
12.1.3.3.1 Product launches 221
12.1.3.3.2 Deals 221
12.1.3.3.3 Expansions 222
12.1.3.4 MnM view 222
12.1.3.4.1 Right to win 222
12.1.3.4.2 Strategic choices 223
12.1.3.4.3 Weaknesses & competitive threats 223
12.1.4 SIEMENS HEALTHINEERS AG 224
12.1.4.1 Business overview 224
12.1.4.2 Products offered 225
12.1.4.3 Recent developments 226
12.1.4.3.1 Product launches 226
12.1.4.3.2 Deals 227
12.1.4.3.3 Expansions 227
12.1.4.4 MnM view 227
12.1.4.4.1 Right to win 227
12.1.4.4.2 Strategic choices 228
12.1.4.4.3 Weaknesses & competitive threats 228
12.1.5 FUJIFILM CORPORATION 229
12.1.5.1 Business overview 229
12.1.5.2 Products offered 230
12.1.5.3 Recent developments 231
12.1.5.3.1 Product launches 231
12.1.5.3.2 Deals 231
12.1.5.3.3 Expansions 232
12.1.5.4 MnM view 232
12.1.5.4.1 Right to win 232
12.1.5.4.2 Strategic choices 232
12.1.5.4.3 Weaknesses & competitive threats 232
12.1.6 HOLOGIC, INC. 233
12.1.6.1 Business overview 233
12.1.6.2 Products offered 234
12.1.6.2.1 Deals 235
12.1.6.2.2 Expansions 236
12.1.7 SAMSUNG ELECTRONICS CO., LTD. 237
12.1.7.1 Business overview 237
12.1.7.2 Products offered 238
12.1.7.3 Recent developments 239
12.1.7.3.1 Product launches 239
12.1.7.3.2 Deals 240
12.1.7.3.3 Other developments 240
12.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 241
12.1.8.1 Business overview 241
12.1.8.2 Products offered 242
12.1.8.3 Recent developments 243
12.1.8.3.1 Product launches 243
12.1.8.3.2 Deals 244
12.1.8.3.3 Other developments 244
12.1.9 SONOSCAPE 245
12.1.9.1 Business overview 245
12.1.9.2 Products offered 245
12.1.10 KONICA MINOLTA, INC 246
12.1.10.1 Business overview 246
12.1.10.2 Products offered 247
12.1.10.3 Recent developments 248
12.1.10.3.1 Product launches & approvals 248
12.1.10.3.2 Deals 248
12.1.11 BUTTERFLY NETWORK 249
12.1.11.1 Business overview 249
12.1.11.2 Products offered 249
12.1.11.3 Recent developments 250
12.1.11.3.1 Product launches 250
12.1.11.3.2 Deals 250
12.1.11.3.3 Expansions 251
12.2 OTHER PLAYERS 252
12.2.1 EXO IMAGING 252
12.2.2 CHISON MEDICAL TECHNOLOGIES CO., LTD 253
12.2.3 ESASOTE 254
12.2.4 CLARIUS 255
12.2.5 EVIDENT VASCULAR 256
12.2.6 SMARTALPHA 257
12.2.7 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING 258
12.2.8 FRONTWAVE IMAGING 259
12.2.9 DELFT IMAGING 260
12.2.10 EDAN INSTRUMENTS, INC 261
12.2.11 ECHONOUS INC. 262
12.2.12 KOIOS MEDICAL 263
12.2.13 BIOTICS AI 264
12.2.14 TERASON 265
12.2.15 BK MEDICAL 266
12.2.16 MAUI IMAGING 267
12.2.17 SONOLOGIC 268
12.2.18 CONTEXTVISION 269
13 APPENDIX 270
13.1 DISCUSSION GUIDE 270
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 274
13.3 CUSTOMIZATION OPTIONS 276
13.4 RELATED REPORTS 276
13.5 AUTHOR DETAILS 277
LIST OF TABLES
TABLE 1 ULTRASOUND AI MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 KEY TECHNOLOGICAL ADVANCEMENTS IN POCUS 49
TABLE 3 ULTRASOUND AI MARKET: IMPACT OF PORTER’S FIVE FORCES 57
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 60
TABLE 5 KEY BUYING CRITERIA, BY END USER 61
TABLE 6 ULTRASOUND AI MARKET: KEY PATENTS, 2022–2024 63
TABLE 7 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2024 (USD THOUSAND) 64
TABLE 8 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020-2024 (USD THOUSAND) 65
TABLE 9 ULTRASOUND AI MARKET: KEY CONFERENCES & EVENTS, 2025–2026 66
TABLE 10 ULTRASOUND AI MARKET: CURRENT UNMET NEEDS 67
TABLE 11 ULTRASOUND AI MARKET: ROLE OF COMPANIES IN ECOSYSTEM 68
TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 69
TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION 75
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 77
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 78
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 23 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION,
2022–2024 (USD THOUSAND) 86
TABLE 24 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, 2024 (USD) 86
TABLE 25 US: MAJOR CPT CODES FOR ULTRASOUND, 2025 87
TABLE 26 ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 89
TABLE 27 AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 90
TABLE 28 AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 90
TABLE 29 HANDHELD: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 91
TABLE 30 CART-BASED: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 92
TABLE 31 POINT OF CARE: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 94
TABLE 32 AI-ENABLED SOLUTIONS/SOFTWARE: ULTRASOUND AI MARKET, BY TYPE,
2023–2030 (USD MILLION) 94
TABLE 33 AI-ENABLED SOLUTIONS/SOFTWARE: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 95
TABLE 34 IMAGE EVALUATION SOFTWARE: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 96
TABLE 35 RADIOLOGY SOFTWARE: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 97
TABLE 36 WORKFLOW PLANNING & SUPPORT SOFTWARE: ULTRASOUND AI MARKET,
BY REGION, 2023–2030 (USD MILLION) 98
TABLE 37 OTHER AI SOLUTIONS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 38 ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 101
TABLE 39 ECHOPAC: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 102
TABLE 40 APLIO: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 41 ACUSON: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 42 BUTTERFLY: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 105
TABLE 43 OTHER BRANDS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 106
TABLE 44 ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 108
TABLE 45 OBSTETRICS/GYNECOLOGY: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 46 COMPARISON OF HUMAN RADIOLOGISTS VS. AI MODELS 111
TABLE 47 RADIOLOGY/GENERAL IMAGING: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 48 ORTHOPEDIC & MUSCULOSKELETAL: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 49 CARDIOLOGY: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 114
TABLE 50 UROLOGICAL: ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 51 OTHER APPLICATIONS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 52 ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 118
TABLE 53 HOSPITALS & SURGICAL CENTERS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 54 IMAGING & SPECIALTY CLINICS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 55 AMBULATORY CARE CENTERS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 56 MATERNITY & FERTILITY CLINICS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 122
TABLE 57 OTHER END USERS: ULTRASOUND AI MARKET, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 58 ULTRASOUND AI MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 59 NUMBER OF UNITS SOLD BY BUTTERFLY NETWORK 125
TABLE 60 NORTH AMERICA: MACROECONOMIC OUTLOOK 126
TABLE 61 NORTH AMERICA: ULTRASOUND AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 62 NORTH AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 128
TABLE 63 NORTH AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 128
TABLE 64 NORTH AMERICA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 129
TABLE 65 NORTH AMERICA: ULTRASOUND AI MARKET, BY BRAND,
2023–2030 (USD MILLION) 129
TABLE 66 NORTH AMERICA: ULTRASOUND AI MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 130
TABLE 67 NORTH AMERICA: ULTRASOUND AI MARKET, BY END USER,
2023–2030 (USD MILLION) 130
TABLE 68 US: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 132
TABLE 69 US: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 132
TABLE 70 US: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 133
TABLE 71 CANADA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 134
TABLE 72 CANADA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 134
TABLE 73 CANADA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 134
TABLE 74 EUROPE: MACROECONOMIC OUTLOOK 135
TABLE 75 EUROPE: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 76 EUROPE: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 136
TABLE 77 EUROPE: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 137
TABLE 78 EUROPE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 137
TABLE 79 EUROPE: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 138
TABLE 80 EUROPE: ULTRASOUND AI MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138
TABLE 81 EUROPE: ULTRASOUND AI MARKET, BY END USER, 2023–2030 (USD MILLION) 139
TABLE 82 GERMANY: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 140
TABLE 83 GERMANY: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 140
TABLE 84 GERMANY: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 140
TABLE 85 UK: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 141
TABLE 86 UK: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 142
TABLE 87 UK: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 88 FRANCE: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 143
TABLE 89 FRANCE : AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 144
TABLE 90 FRANCE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 144
TABLE 91 ITALY: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 145
TABLE 92 ITALY: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 145
TABLE 93 ITALY: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 94 SPAIN: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 147
TABLE 95 SPAIN: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 147
TABLE 96 SPAIN: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 148
TABLE 97 REST OF EUROPE: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 149
TABLE 98 REST OF EUROPE: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 149
TABLE 99 REST OF EUROPE: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 100 ASIA PACIFIC: ULTRASOUND AI MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 101 ASIA PACIFIC: MACROECONOMIC OUTLOOK 151
TABLE 102 ASIA PACIFIC: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 152
TABLE 103 ASIA PACIFIC: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 153
TABLE 104 ASIA PACIFIC: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 105 ASIA PACIFIC: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 154
TABLE 106 ASIA PACIFIC: ULTRASOUND AI MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 154
TABLE 107 ASIA PACIFIC: ULTRASOUND AI MARKET, BY END USER,
2023–2030 (USD MILLION) 155
TABLE 108 CHINA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 157
TABLE 109 CHINA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 157
TABLE 110 CHINA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 111 JAPAN: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 159
TABLE 112 JAPAN: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 159
TABLE 113 JAPAN: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 114 INDIA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 161
TABLE 115 INDIA: AI-ENABLED ULTRASOUND SYSTEMS, MARKET, BY TYPE,
2023–2030 MILLION) 161
TABLE 116 INDIA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 117 AUSTRALIA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 163
TABLE 118 AUSTRALIA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 163
TABLE 119 AUSTRALIA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 120 SOUTH KOREA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 165
TABLE 121 SOUTH KOREA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 165
TABLE 122 SOUTH KOREA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 123 REST OF ASIA PACIFIC: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 167
TABLE 124 REST OF ASIA PACIFIC: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 MILLION) 168
TABLE 125 REST OF ASIA PACIFIC: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 126 LATIN AMERICA: MACROECONOMIC OUTLOOK 169
TABLE 127 LATIN AMERICA: ULTRASOUND AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 170
TABLE 128 LATIN AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 170
TABLE 129 LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 171
TABLE 130 LATIN AMERICA: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 131 LATIN AMERICA: ULTRASOUND AI MARKET, BY BRAND, 2023–2030 (USD MILLION) 172
TABLE 132 LATIN AMERICA: ULTRASOUND AI MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 172
TABLE 133 LATIN AMERICA: ULTRASOUND AI MARKET, BY END USER,
2023–2030 (USD MILLION) 173
TABLE 134 BRAZIL: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 174
TABLE 135 BRAZIL: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 174
TABLE 136 BRAZIL: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 137 MEXICO: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 176
TABLE 138 MEXICO: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE,
2023–2030 MILLION) 176
TABLE 139 MEXICO: AI-ENABLED ULTRASOUND SOLUTIONS/SOFTWARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 140 REST OF LATIN AMERICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 177
TABLE 141 REST OF LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 MILLION) 177
TABLE 142 REST OF LATIN AMERICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 143 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 179
TABLE 144 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 179
TABLE 145 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 180
TABLE 146 MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 MILLION) 180
TABLE 147 MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 148 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY BRAND,
2023–2030 (USD MILLION) 181
TABLE 149 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 182
TABLE 150 MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY END USER,
2023–2030 (USD MILLION) 182
TABLE 151 GCC COUNTRIES: ULTRASOUND AI MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 183
TABLE 152 GCC COUNTRIES: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 MILLION) 184
TABLE 153 GCC COUNTRIES: AI-ENABLED ULTRASOUND SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 154 REST OF MIDDLE EAST & AFRICA: ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 185
TABLE 155 REST OF MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 MILLION) 185
TABLE 156 REST OF MIDDLE EAST & AFRICA: AI-ENABLED ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 157 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ULTRASOUND
AI MARKET 188
TABLE 158 ULTRASOUND AI MARKET: DEGREE OF COMPETITION 190
TABLE 159 ULTRASOUND MARKET: REGION FOOTPRINT 195
TABLE 160 ULTRASOUND AI MARKET: PRODUCT FOOTPRINT 196
TABLE 161 ULTRASOUND AI MARKET: APPLICATION FOOTPRINT 197
TABLE 162 ULTRASOUND AI MARKET: END USER FOOTPRINT 198
TABLE 163 ULTRASOUND AI MARKET: DETAILED LIST OF KEY STARTUPS/SMES 201
TABLE 164 ULTRASOUND AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 202
TABLE 165 ULTRASOUND AI MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2025 206
TABLE 166 ULTRASOUND AI MARKET: DEALS, JANUARY 2021–AUGUST 2025 207
TABLE 167 GE HEALTHCARE: COMPANY OVERVIEW 208
TABLE 168 GE HEALTHCARE: PRODUCTS OFFERED 209
TABLE 169 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–AUGUST 2025 210
TABLE 170 GE HEALTHCARE: DEALS, JANUARY 2021– AUGUST 2025 212
TABLE 171 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021– AUGUST 2025 212
TABLE 172 PHILIPS HEALTHCARE: COMPANY OVERVIEW 214
TABLE 173 PHILIPS HEALTHCARE: PRODUCTS OFFERED 215
TABLE 174 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021– AUGUST 2025 217
TABLE 175 PHILIPS HEALTHCARE: DEALS, JANUARY 2021– AUGUST 2025 218
TABLE 176 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 219
TABLE 177 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 220
TABLE 178 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021– AUGUST 2025 221
TABLE 179 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021– AUGUST 2025 221
TABLE 180 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS,
JANUARY 2021– AUGUST 2025 222
TABLE 181 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 224
TABLE 182 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 225
TABLE 183 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES,
JANUARY 2021– AUGUST 2025 226
TABLE 184 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021– AUGUST 2025 227
TABLE 185 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021– AUGUST 2025 227
TABLE 186 FUJIFILM CORPORATION: COMPANY OVERVIEW 229
TABLE 187 FUJIFILM CORPORATION: PRODUCTS OFFERED 230
TABLE 188 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 231
TABLE 189 FUJIFILM CORPORATION: DEALS, JANUARY 2021– AUGUST 2025 231
TABLE 190 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2021– AUGUST 2025 232
TABLE 191 HOLOGIC, INC.: COMPANY OVERVIEW 233
TABLE 192 HOLOGIC, INC.: PRODUCTS OFFERED 234
TABLE 193 HOLOGIC, INC.: DEALS, JANUARY 2021– AUGUST 2025 235
TABLE 194 HOLOGIC, INC.: EXPANSIONS, JANUARY 2021– AUGUST 2025 236
TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW 237
TABLE 196 SAMSUNG ELECTRONICS CO., LTD.: PRODUCTS OFFERED 238
TABLE 197 SAMSUNG ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 239
TABLE 198 SAMSUNG ELECTRONICS CO., LTD.: DEALS, JANUARY 2021– AUGUST 2025 240
TABLE 199 SAMSUNG ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025 240
TABLE 200 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY OVERVIEW 241
TABLE 201 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCTS OFFERED 242
TABLE 202 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 243
TABLE 203 MINDRAY MEDICAL INTERNATIONAL LIMITED: DEALS,
JANUARY 2021– AUGUST 2025 244
TABLE 204 MINDRAY MEDICAL INTERNATIONAL LIMITED: OTHER DEVELOPMENTS,
JANUARY 2021– AUGUST 2025 244
TABLE 205 SONOSCAPE: COMPANY OVERVIEW 245
TABLE 206 SONOSCAPE: PRODUCTS OFFERED 245
TABLE 207 KONICA MINOLTA, INC.: COMPANY OVERVIEW 246
TABLE 208 KONICA MINOLTA, INC: PRODUCTS OFFERED 247
TABLE 209 KONICA MINOLTA, INC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021– AUGUST 2025 248
TABLE 210 KONICA MINOLTA, INC: DEALS, JANUARY 2021– AUGUST 2025 248
TABLE 211 BUTTERFLY NETWORK: COMPANY OVERVIEW 249
TABLE 212 BUTTERFLY NETWORK: PRODUCTS OFFERED 249
TABLE 213 BUTTERFLY NETWORK: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2025 250
TABLE 214 BUTTERFLY NETWORK: DEALS, JANUARY 2021– AUGUST 2025 250
TABLE 215 BUTTERFLY NETWORK: EXPANSIONS, JANUARY 2021– AUGUST 2025 251
TABLE 216 EXO IMAGING: COMPANY OVERVIEW 252
TABLE 217 CHISON MEDICAL TECHNOLOGIES CO., LTD: COMPANY OVERVIEW 253
TABLE 218 ESASOTE: COMPANY OVERVIEW 254
TABLE 219 CLARIUS: COMPANY OVERVIEW 255
TABLE 220 EVIDENT VASCULAR: COMPANY OVERVIEW 256
TABLE 221 SMARTALPHA: COMPANY OVERVIEW 257
TABLE 222 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING:
COMPANY OVERVIEW 258
TABLE 223 FRONTWAVE IMAGING: COMPANY OVERVIEW 259
TABLE 224 DELFT IMAGING: COMPANY OVERVIEW 260
TABLE 225 EDAN INSTRUMENTS, INC: COMPANY OVERVIEW 261
TABLE 226 ECHONOUS INC.: COMPANY OVERVIEW 262
TABLE 227 KOIOS MEDICAL: COMPANY OVERVIEW 263
TABLE 228 BIOTICS AI: COMPANY OVERVIEW 264
TABLE 229 TERASON: COMPANY OVERVIEW 265
TABLE 230 BK MEDICAL: COMPANY OVERVIEW 266
TABLE 231 MAUI IMAGING: COMPANY OVERVIEW 267
TABLE 232 SONOLOGIC: COMPANY OVERVIEW 268
TABLE 233 CONTEXTVISION: COMPANY OVERVIEW 269
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 28
FIGURE 2 KEY SECONDARY SOURCES 29
FIGURE 3 PRIMARY SOURCES 31
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 32
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 34
FIGURE 7 ULTRASOUND AI MARKET SIZE ESTIMATION: APPROACH 1
(COMPANY REVENUE ESTIMATION) 35
FIGURE 8 ULTRASOUND AI MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 36
FIGURE 9 TOP-DOWN APPROACH 37
FIGURE 10 GLOBAL MARKET GROWTH PROJECTIONS 38
FIGURE 11 DATA TRIANGULATION METHODOLOGY 39
FIGURE 12 ULTRASOUND AI MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 42
FIGURE 13 ULTRASOUND AI MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43
FIGURE 14 ULTRASOUND AI MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43
FIGURE 15 INTEGRATION WITH OTHER IMAGING MODALITIES TO DRIVE MARKET 45
FIGURE 16 HOSPITALS & SURGICAL CENTERS TO ACCOUNT FOR LARGEST MARKET
SHARE IN 2025 46
FIGURE 17 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
FIGURE 18 ULTRASOUND AI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 48
FIGURE 19 ULTRASOUND AI MARKET: VALUE CHAIN ANALYSIS 55
FIGURE 20 ULTRASOUND AI MARKET: SUPPLY CHAIN ANALYSIS 57
FIGURE 21 ULTRASOUND AI MARKET: PORTER’S FIVE FORCES 58
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 59
FIGURE 23 KEY BUYING CRITERIA, BY END USER 60
FIGURE 24 PATENT ANALYSIS FOR ULTRASOUND AI MARKET (JANUARY 2014–AUGUST 62
FIGURE 25 ULTRASOUND AI MARKET: ECOSYSTEM ANALYSIS 67
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 27 INVESTMENT & FUNDING SCENARIO, 2019–2023 82
FIGURE 28 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 83
FIGURE 29 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 83
FIGURE 30 AVERAGE SELLING PRICE OF ULTRASOUND AI, BY REGION, 2022–2024 (USD) 85
FIGURE 31 NORTH AMERICA: ULTRASOUND AI MARKET SNAPSHOT 127
FIGURE 32 ASIA PACIFIC: ULTRASOUND AI MARKET SNAPSHOT 152
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN ULTRASOUND AI MARKET,
2021–2024 (USD BILLION) 189
FIGURE 34 ULTRASOUND AI MARKET SHARE ANALYSIS (2024) 190
FIGURE 35 RANKING OF KEY PLAYERS IN ULTRASOUND AI MARKET, 2024 191
FIGURE 36 ULTRASOUND AI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 193
FIGURE 37 ULTRASOUND AI MARKET: COMPANY FOOTPRINT 194
FIGURE 38 ULTRASOUND AI MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 200
FIGURE 39 EV/EBITDA OF KEY VENDORS 204
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 204
FIGURE 41 ULTRASOUND AI MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 205
FIGURE 42 GE HEALTHCARE: COMPANY SNAPSHOT 209
FIGURE 43 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 215
FIGURE 44 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 220
FIGURE 45 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 225
FIGURE 46 FUJIFILM CORPORATION: COMPANY SNAPSHOT 230
FIGURE 47 HOLOGIC, INC.: COMPANY SNAPSHOT 234
FIGURE 48 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 238
FIGURE 49 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT 241
FIGURE 50 KONICA MINOLTA, INC: COMPANY SNAPSHOT 247
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31